KUW-14376-53003
4 vaccinations
2 coded responses
21 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 951 / CA
- Registered
- 2021-06-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
JB2-25811-95320
Child or adolescent in my care · Male · 2022-07-19
SDE-30086-95898
Child or adolescent in my care · Male · 2022-07-19
Timeline
-
2021-05-15
Dose 1 — Pfizer-BioNTech
-
2021-06-05
Dose 2 — Pfizer-BioNTech
-
2021-06-06
Registered in v-safe
-
2021-06-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-06-07
- 2021-06-08
-
2021-06-09
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: FairFree text: Lightheaded/dizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-10
- 2021-06-11
- 2021-06-12
- 2021-06-19
- 2021-06-26
- 2021-07-03
- 2021-07-10
- 2021-07-17
-
2021-09-04
Survey response — 3 months, dose 2MedDRA: Postpartum state, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Postpartum preeclampsiaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-04
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-28
Dose 3 — Pfizer-BioNTech
- 2021-12-04
- 2021-12-04
- 2021-12-09
- 2022-01-27
-
2022-04-21
Dose 4 — Pfizer-BioNTech
- 2022-04-28
- 2022-07-21
- 2022-10-20
- 2023-04-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-15 | Pfizer-BioNTech | |
| 2 | 2021-06-05 | Pfizer-BioNTech | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
| 4 | 2022-04-21 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Lightheaded/dizzy
Release 9 — 3 months, dose 2
Symptoms: Postpartum preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Postpartum state | ✓ | · | ✓ |
| SD | Pre-eclampsia | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release